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Abstract 
Cyanobacteria are widespread prokaryotic photosynthetic organisms with an extreme 
capability to withstand different environment conditions. This adaptive capacity is 
attributed to the production of secondary compounds with antioxidant, photoprotective 
and humectant properties among others. In recent years marine cyanobacteria extracts 
and compounds revealed potential for biotechnology, namely in the pharmacological 
field. The isolation of marine cyanobacteria from different latitudes and its preservation 
ex situ is thus of crucial importance in order to trace their bioactive potential. In this work, 
coastal marine samples were collected from beaches of two Cape Verde Islands, Santo 
Antão and São Vicente. The objective was to contribute to the study of the cyanobacteria 
diversity of the archipelago and to isolate strains in order to infer about its 
biotechnological potential. From a total of 25 samples collected in São Vicente and 3 
samples collected in Santo Antão, 20 cyanobacteria strains were isolated using both 
solid and liquid Z8 medium. Isolates were identified by morphometry and molecular tools, 
through the sequencing of the 16S rRNA gene. All the isolated strains are filamentous 
non-heterocystous forms. The phylogenetic analysis reveals strains that might belong to 
new genera, which contributes to enrich the diversity that occurs within this group of 
organisms. 
To infer about the bioactive potential, strains were cultured in large scale for biomass 
production and methanolic extracts were prepared and tested for cytotoxicity using the 
normal keratinocytes cell line HaCat, the normal endothelial cell line hCMEC/D3, the 
hepatic carcinoma cell line HepG2, the colon carcinoma cell line RKO and the breast 
carcinoma cell line T47D. Cellular viability was evaluated by the 3-(4.5-dimethylthiazol-
2-yl)-2.5-diphenyltetrazolium bromide (MTT) assay after 24 and 48 hours of exposure to 
the extracts at a final concentration of 100, 75, 50, 25, 12,5 and 6,25 µg mL-1. The MTT 
results revealed both toxic and no toxic responses revealing strains with potential for 
further fractionation. Among those the strain JM1B and JM5A induced selective 
cytotoxicity against the T47D cell line, revealing potential as anticancer. The strains PL1 
and PL2 induced selective toxicity against the keratinocytes cell line, while strains VV5, 
VV3, VV3B and VV13 induced a proliferation of the same cell line. In both cases results 
revealed the potential of the strains for skin care applications.  
 
 
Key words: Cape Verde; Cyanobacteria, Diversity; Natural compounds; Bioactivity. 
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Resumo 
As cianobactérias são organismos procarióticos fotossintéticos com uma capacidade 
extrema de suportar diferentes condições ambientais. Essa capacidade adaptativa é 
atribuída à produção de compostos secundários com propriedades antioxidantes, 
fotoprotetoras e hidratantes, entre outras. Nos últimos anos, os extratos e compostos de 
cianobactérias marinhas têm revelado potencial para aplicação em biotecnologia, 
principalmente no campo farmacológico. O isolamento de cianobactérias marinhas de 
diferentes latitudes e sua preservação ex situ reveste-se assim de grande importância 
no sentido de avaliar o seu potencial bioativo. Este trabalho teve como base amostras 
recolhidas de zonas costeiras de duas ilhas de Cabo Verde, Santo Antão e São Vicente. 
O objetivo foi contribuir para o estudo da diversidade de cianobactérias do arquipélago 
e isolar estirpes para estudo sobre seu potencial biotecnológico. De um total de 25 
amostras recolhidas em São Vicente e 3 amostras recolhidas em Santo Antão, 
conseguiu-se o isolamento de 20 estirpes usando meio Z8 sólido e líquido. Os isolados 
foram identificados por morfometria e ferramentas moleculares, através da 
sequenciação do gene 16S rRNA. Todas as estirpes isoladas são formas filamentosas 
não formadoras de heterocistos. A análise filogenética revela estirpes que podem 
pertencer a novos géneros, o que contribui para enriquecer a diversidade que ocorre 
dentro deste grupo de organismos. 
Para avaliação do potencial bioativo, os isolados foram cultivados em larga escala para 
produção de biomassa e preparados extratos metanólicos. Os extratos foram testados 
quanto à citotoxicidade usando a linha celular normal de queratinócitos HaCat, a linha 
celular endotelial normal hCMEC / D3, a linha celular de carcinoma hepático HepG2, a 
linha celular RKO de carcinoma do cólon e linha celular T47D de carcinoma da mama. 
A viabilidade celular foi avaliada pelo ensaio de brometo de 3- (4,5-dimetiltiazol-2-il) -
2,5-difeniltetrazólio (MTT) após 24 e 48 horas de exposição aos extratos, numa 
concentração final de 100, 75, 50, 25, 12, 5 e 6,25 µg mL-1. Os resultados do MTT 
revelaram respostas de citotoxicidade e proliferação seletiva, permitindo a seleção de 
algumas estirpes para posterior fracionamento. Entre estas, as estirpes JM1B e JM5A 
induziram citotoxicidade seletiva contra a linhagem de células T47D, revelando potencial 
anticancerigeno. As estirpes PL1 e PL2 induziram toxicidade seletiva contra a linha 
celular de queratinócitos, enquanto as estirpes VV5, VV3, VV3B e VV13 induziram uma 
proliferação da mesma linha celular. Nos dois casos, os resultados revelam o potencial 
das estirpes para aplicações cutâneas. 
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1. Introduction 
 
1.1. Cape Verde Archipelago 
 
Cape Verde Archipelago (CVA) is a group of ten volcanic islands located in the Tropical 
Eastern Atlantic, around the African coast (Figure 1). The archipelago main islands are 
split into two groups composed by six northern Barlavento (windward) Isles and four 
southern Sotavento isles. The origins of the archipelago are thought to be associated 
with hotspot activity impinging on the old oceanic lithosphere. Together with the Canary 
Islands, Madeira and Azores, Cape Verde belong to the Macaronesia biogeographic 
region [1]. This region is an important transitional climatic zone that encompasses a large 
part of the eastern north Atlantic, which is influenced by the semi-permanent Azores 
high-pressure system, prevailing north-easterly trade winds and the surrounding ocean, 
The Cape Verde climate ranges from tropical dry to semi-desert, mainly governed by 
seasonal changes in the location of the Azores anticyclone, the Intertropical 
Convergence Zone and arid Atlantic air masses [2]. 
Cape Verde precipitation is limited, and typically confined to the raining season (August-
October). The two major influences on Cape Verde precipitation are the African Monsoon 
and African Easterly waves. As such, decadal changes in Cape Verde precipitation 
mirror precipitation trends across the West African Sahel, as they share the same 
generation mechanism [2]. 
São Vicente, one of the Barlavento (windward) islands, has an extension of 227 km2. 
The depth of the sea floor between São Vicente and Santa Luzia does not reach 50 m, 
whereas between São Vicente and Santo Antão it reaches 500 m. Its outline resembles 
that of a rhombus with a major (E–W) diagonal of about 24 km and a minor (N–S) 
diagonal of about 16 km [3].  
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Santo Antão is the most north-western island of the CVA and the second largest of the 
ten main islands, with an area of 779 km2. Santo Antão consists of alkaline volcanic rocks 
that vary in composition from nefelinite and basanite to phonolite, as for many volcanic  
oceanic islands [4]. The island has a rugged relief with the highest point at 1979 m. North-
easterly trade winds ensure a humid climate and high erosion rates in the north and 
north-western parts of Santo Antão, which has many deeply dissected valleys where 
older successions of composite lava flows and associated dyke swarms are well 
exposed.  
 
 
 
Figure 1 - Map of Cape verde archipelago 
  
 
 
1.2. Cyanobacteria 
 
Cyanobacteria are prokaryotic organisms with photosynthetic capacity but that are able 
to use also anaerobic respiration and to fix atmospheric nitrogen. In the marine 
environment cyanobacteria are considered the main producer of the phytoplankton 
community food chain as they produce 50% of the biomass [5]. Also known as 
cyanophyta or blue-green algae, cyanobacteria have a great physiological  and 
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morphological variability, which might be the base for their global distribution [6]. In fact, 
cyanobacteria have a wide distribution and can be found in aquatic environments as well 
as in terrestrial environments and even in extreme conditions such as a high salinity [7]  
high and  
low temperature [8]. In order to survive to such extreme conditions through a long 
evolution period cyanobacteria have developed mechanisms of adaptation that include 
the production of sundry secondary metabolites [9], with antioxidant, photoprotective, 
moisturizing, allelopathic and toxic properties, which includes pigments, 
polysaccharides, fatty acids and peptides [10]. 
The bioactive properties of cyanobacteria, the high growth rates and the ability to grow 
autotrophically which makes their cultivation simple and cost-effective, have attracted an 
increasing interest by a wide range of industries, such as the food industry, the cosmetic 
industry, the pharmacological industry, the energetic industry and agriculture. In fact 
cyanobacteria have been considered a rich source of compounds for use as food 
additives, cosmetics, antitumor, antibacterial and antiviral drugs, biofuels as well as 
organic fertilizers [11].  
The high interest in cyanobacteria has led to further research on strains from different 
habitats to obtain value-added strains for industry and agriculture. This research involves 
collecting samples in the wild, isolation, identification and culture. In order to maintain 
the isolated strains, biologic specimens must be deposited in collections, being then 
available for investigation. 
 
 
1.2.1. Cyanobacteria taxonomy 
 
The cyanobacterial phylum is very diversified in terms of morphology, including 
unicellular, colonial and filamentous forms. In some filamentous strains a cell 
differentiation is presented by the production of specialized cells involved in nitrogen 
fixation, the heterocysts, and resting cells that can resist to environmental stress, the 
akinetes. Some genera also produce small fragments with different size  and shape, the 
hormogonia, used for dispersal and host infection [12]. 
Traditionally, cyanobacteria were classified according the International Code of Botanical 
Nomenclature due to the ability to perform oxygenic photosynthesis and the similarity to 
the structure of eukaryotic chloroplasts. However, due to their prokaryotic nature 
cyanobacteria are also classified according to the International Code of Nomenclature of 
Bacteria. Currently the two aproaches prevail, the botanical [13] and the bacterial [14]. 
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According to the botanical classification cyanobacteria are classified into five Orders 
while according to the Bacterial approach cyanobacteria are classified into five 
Subsections. The five orders and subsections broadly coincide as described in Table 1, 
where the main characteristics are presented.  
Although the traditional classification and identification of cyanobacteria has been based 
on morphological characteristics, the advances in molecular biology led to the use of 
molecular markers. A combination of different approaches has thus been lately adopted, 
which includes not only the morphological description of the specimens but also a 
genotypic analysis, namely by using the small subunit ribosomal RNA, the 16S rRNA 
gene [15]. This new polyphasic approach makes it possible to overcome some difficulties 
in morphology-only identification due to the small size of many strains and morphological 
changes during strain cultivation or long-term maintenance in the laboratory [15]. 
 
Table 1 - Main characteristics and genus of the 5 orders/subsections of the phylum 
cyanobacteria. 
Orders/ 
Subsections 
Main characteristics Genus 
Chroococcales 
Subsection I 
Unicellular or not 
aggragated. Reproduction by 
binary fission in one, two or 
more plans. 
Chroococcus, Cyanobacterium, 
Cyanothece,Dactylococcopsis, 
Gloeobacter, Gloeothece, Microcystis, 
Prochlorococcus, Synechococcus, 
Synechocystis 
Pleurocapsales 
Subsection II 
Unicellular. United by exterior 
walls or gel matrix. 
Reproduction by multiple 
fusion. The tilakoid cells are 
smaller than the stem cells. 
 
Cyanocystis, Dermocarpella, 
Myxosarcina,  Stanieria, Xenococcus 
Oscillatoriales 
Subsection III 
Filamentous. Reproduction 
by binary fission in one plan. 
Unbranched and uniseriate 
trichomes. Trichomes without 
heterocysts or akintes. 
Arthrospira, Lyngbya, Leptolyngbya, 
Microcoleus, Oscillatoria, Planktothrix, 
Pseudoanabaena, Trichodesmium 
Nostocales 
Subsection IV 
Filamentous. Reproduction 
by binary fission in one plan. 
Unbranched and uniseriate 
trichomes. Trichomes with 
heterocysts or akintes. 
Anabaena, Anabaenopsis, 
Aphanizomenon, Cylindrospermopsis, 
Gloeotrichia, Nodularia, Nostoc, Rivularia, 
Stigonematales 
Subsection V 
Filamentous. Reproduction 
by binary fission periodically 
or in more than one plan. 
Multiseriated trichomes or 
trichomes with various types 
of branches. Trichomes with 
heterocysts or akintes. 
Loriella, Geitleria, Nostochopsis, Westiella 
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1.2.2. Cyanobacteria isolation and preservation  
 
Although for several years cyanobacteria were found to be difficult or even impossible to 
isolate, Allen (1968) and Huges (1958) proved that it was possible to isolate and maintain 
ex-situ cyanobacteria in laboratory culture, for several years [16],[17].To initiate the 
process of cyanobacteria isolation, environmental samples are collected, and their origin 
noted. Upon arrival to the laboratory, it is critical to evaluate the sample material content 
in order to identify cyanobacteria that have capacity to grow in specific medium, since 
the characteristics that an organism must develop in a given environment are used as 
selective factors in the isolation process. This evaluation is carefully performed with the 
aid of a microscope [18]. After, it is crucial the choice of the most appropriate medium to 
their successful isolation. The medium used for enrichment is generally liquid and have 
a nutritional composition that enables the development of specific organisms to the 
detriment of competitors. These media may be selective enrichment media, if it involves 
the addition of inhibitory substances (eg antibiotics, antifungals) that suppress the growth 
of most organisms with the exception of the organism to be isolated [19]. Following the 
collection, identification, and characterization of organisms, environmental samples 
should be enriched with the selected medium. 
In addition to isolation in liquid media, cyanobacteria can also be isolated using solid 
media such by inoculum streak and streak seeding [18] or selecting organisms by 
micromanipulation, a technique that requires practice and patience [20], or a combination 
of these different techniques. The micromanipulation is performed with the aid of an 
optical microscope and consists of the selection of the organism of interest, ideally 
present in liquid medium, using microcapillaries [20]. The obtained cultures should be 
monitored and successively picked until isolation is confirmed [20]. 
After isolation and classification, strains must be preserved in controlled culture 
conditions in order to ensure the ex-situ preservation. This ex-situ preservation of 
microorganisms and the public access to microbial specimens is the aim of the microbial 
domain of Biological Resource Centres (mBRC), the so-called microbial Culture 
Collections.  
Blue Biotechnology and Ecotoxicology (BBE) Culture Collection (LEGE-CC) 
http://lege.ciimar.up.pt/ is a biological resource center of the Interdisciplinary Marine and 
Environmental Research Center (CIIMAR) Portugal. The collection currently comprises 
about 1000 of cyanobacteria and microalgae strains collected from different sites, mainly 
in mainland Portugal including Madeira and Azores Islands, but also elsewhere (e.g. 
Australia, Brazil, Colombia, Morocco, Mexico). LEGE CC strains are derived from many 
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environments, 93% of those are from aquatic environments (2% hypersaline, 46% 
marine, 11% brackish and 34% freshwater), 3% from terrestrial environments and 4% 
with unknown origin. They are also producers of secondary metabolites, such as 
microcystin, that have toxic effects on human beings [22]. One of the main purposes of 
LEGE-CC is to provide living organisms, and/or related information, to third parties for 
use in research and development activities. It is therefore essential that strains existing 
(or to be included) in the LEGE-CC crop collection are properly isolated and appropriately 
characterized in order to interest potential users [21].  
 
 
1.2.3. Cyanobacteria bioactive compounds 
 
A main reason why the study of cyanobacteria is so attractable is the production of 
bioactive compounds with diverse biotechnological applications. Cyanobacteria 
bioactive compounds are mainly secondary metabolites. These are metabolites 
produced by an organism in which a role in primary functions such as growth or 
reproduction has not been found [23]. They are responsible for umpteen functions such 
as allelopathy [24] and defense [25], although they are not absolutely required for the 
survival of the organism.  
The high biodiversity of cyanobacteria in nature is reflected also in a high chemical 
diversity and bioactive potential. The range of bioactive secondary compounds from 
cyanobacteria includes alkaloids, peptides, lipopeptides, amino acids and fatty acids 
[26], being cyanobacteria considered a good source of compounds for biotechnology 
applications, namely for pharmaceutical and therapeutic application [27],[28],[29],[30]. In 
fact, in the last few years cyanobacteria have gained a lot of attention being considered 
one of the most promising sources of natural compounds with antibacterial [31], antiviral 
[32], antifungal, anti-inflammatory, algicide [33], anticancer [34, 35], and antiparasitic 
activity [26] (Table 2) 
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Table 2 - Marine cyanobacteria compounds with bioactive potential (anticancer, anti-
inflammatory, antioxidant, antiparasitic, photoprotective and whitening). 
 Compound or extract Source 
Class of 
compound Biological Model Reference 
An
tic
an
ce
r 
Lagunamides Lyngbya majuscula 
Cyclic 
depsipeptide 
Cytotoxicity against 
a panel of cancer 
cell lines 
[36] 
Aurilides Lyngbya majuscula 
Cyclic 
depsipeptide 
Cytotoxicity against 
NCI-460 and neuro-
2a mouse 
neuroblastoma cells 
[37] 
Isomalyngamide Lyngbya majuscula 
Fatty acid 
amides 
Activity against 
tumor cell migration 
through the 1 
integrin-mediated 
antimetastatic 
pathway 
[38] 
Palmyramide A Lyngbya majuscula 
Cyclic 
depsipeptide 
Blocking of sodium 
channels in neuro-
2a cells and 
cytotoxicity against 
H460 human lung 
cancer cells 
[39] 
Biselyngbyaside Lyngbya sp Glicomacrolide 
Cytotoxicity against 
a panel of cancer 
cell lines 
[40] 
Bisebromoamide Lyngbya sp Peptide 
Cytotoxicity against 
a panel of cancer 
cell lines 
[41] 
Apratoxins Lyngbya Cyclic Depsipeptide 
Cytotoxicity 
againsta panel of 
cancer cell line 
[42, 43] 
An
ti-
in
fla
m
m
at
or
y  
Sacran Aphanothece sacrum Polysaccharide Mice [44] 
An
tio
xi
da
nt
 
Scytonemina 
(SCY) Scytonema sp. Alkaloid Cyanobacteria cells [45] 
Mycosporine-like 
amino acids 
(MAA) 
Nostoc 
sphaericum - 
Cyanobacteria cells 
 [46] 
MAAs and SCY 
Nostoc 
commune 
 
- Cyanobacteria cells  [47] 
Exopolysaccharid
es (EPS) 
Nostoc 
commune. Polysaccharides 
Caenorhadiris 
elegants [48] 
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Table 2 (Cont.) 
 Compound or 
extract Source 
Class of 
compound 
Biological 
Model Reference 
An
tip
ar
as
iti
c 
(L
ei
sh
m
an
ia
) Venturamide B Oscillatoria sp. Cyclic peptides Leishmania donovani [49] 
Gallinamide A Schizothrix sp. Peptide L. donovani [49] 
An
tip
ar
as
iti
c 
(M
al
ar
ia
)  Lagunamide A Lyngbya majusucla 
Cyclic 
depsipeptides 
Plasmodium 
falciparum [50] 
Venturamide A Oscillatoria sp Cyclic hexapeptides P. falciparum [51] 
An
tip
ar
as
iti
c 
(T
rip
an
os
so
m
a)
 
Venturamide B Oscillatoria sp. Cyclic peptides Tripamossona.  Cruzi [49] 
Dragonamide E Lyngbya majusucla Lipopeptides L. donovani [52] 
Ph
ot
o 
Pr
ot
ec
tio
n 
 
SCY Arthrospira platensis Alkaloid 
Cyanobacterial 
cells 
 
[45] 
MAAs and SCY Lyngbya sp. _ Cyanobacterial cells [53] 
W
hi
te
ni
ng
 Chloroform-
methanol extract 
Oscilnorlatoria 
agardhii - 
Tyrosinase 
activity assay [54] 
C-phycocyanin Spirulina Pigment B16F10 [55] 
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2. Objectives 
 
The main aim of this work was to contribute to the study of the biodiversity and the 
biotechnological potential of cyanobacteria collected from Cape Verde Islands. The 
environmental samples included in this study were collected from two islands of the 
archipelago, São Vicente and Santo Antão. Samples were collected by members of the 
Blue Biotechnology and Ecotoxicology Group (BBE) from the Centre of Marine and 
Environmental Research (CIIMAR). 
 
Based on this main goal, specific tasks were performed, which included: 
 
1. Isolation of cyanobacteria strains using both solid and liquid Z8 medium; 
2. Identification of the isolated cyanobacteria using a morphological and a molecular 
approach;  
3. Culture of isolated cyanobacteria strains for biomass production.  
4. Preparation of cyanobacteria extracts; 
5. Evaluation of the bioactive potential of cyanobacteria extracts: 
a. evaluation of the anticancer potential using cancer cell lines and normal cell 
lines. 
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3. Material and Methods 
 
3.1. Sampling 
 
The biological environmental samples were collected in April 2018 in two Cape Verde 
Islands, São Vicente and Santo Antão. In São Vicente, samples were collected in Baía 
das Gatas, Praia da Laginha, Cova da Inglesa, Salamansa and Calhau. In Santo Antão 
samples were collected in Ponta do Sol (Figure 2; Table 1). 
 
 
Figure 2 - Samples locations in são Vicente (Baia das Gatas, Praia da Laginha, Cova da Inglesa, Salamansa, 
Calhau) and Santo Antão (Ponta do Sol). 
 
The collected material consisted in rock scrapes along the coast and sea water samples. 
After collection the material was stored in thermal bags and kept refrigerated until 
processing. 
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Table 3 - Sampling sites and environmental samples collected from São Vicente and 
santo Antão islands (data kindly provided by João Morais, BBE-CIIMAR). 
Island Site Sampling Date Original label 
São 
Vicente 
Baía das Gatas 14/04/2018 and 20/04/2018 JM1 
Baía das Gatas 14/04/2018 JM2 
Baía das Gatas 14/04/2018 VR1 
Baía das Gatas 14/04/2018 and 20/04/2018 VR2 
Baía das Gatas 14/04/2018 VR3 
Baía das Gatas 14/04/2018 VV1 
Baía das Gatas 14/04/2018 PL1 
Baía das Gatas 14/04/2018 PL2 
Baía das Gatas 14/04/2018 PL3 
Calhau 24/04/2018 VV8 
Calhau 24/04/2018 VV9 
Calhau 24/04/2018 VV10 
Cova da Inglesa (Lazareto) 21/04/2018 VV5 
Cova da Inglesa (Lazareto) 21/04/2018 JM3 
Cova da Inglesa (Lazareto) 21/04/2018 JM4 
Cova da Inglesa (Lazareto) 21/04/2018 JM5 
Praia da Laginha 21/04/2018 VV2 
Praia da Laginha 21/04/2018 VV3 
Praia da Laginha 21/04/2018 VV4 
Salamansa 23/04/2018 VV6 
Salamansa 23/04/2018 VR4 
Salamansa 23/04/2018 VV7 
Salamansa 23/04/2018 VR5 
Salamansa 23/04/2018 VR6 
Salamansa 23/04/2018 VR7 
Santo 
Antão 
Ponta do Sol 25/04/2018 VV11 
Ponta do Sol 25/04/2018 VV12 
Ponta do Sol 25/04/2018 VV13 
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3.2. Isolation of cyanobacteria strains 
 
The isolation of cyanobacteria from environmental samples was performed using both 
liquid and solid Z8 culture medium, supplemented with 25g/L NaCl   [56], in aseptic 
conditions. All the glass material used was autoclaved (Tuttnauer 3870 ELV-D, The 
Netherlands) for 20 min at 121°C. The preparation of the medium and the entire isolation 
process was carried out in a laminar flow chamber (Telstar Bio II Advance, Spain) 
previously disinfected with 70% alcohol and exposed to UV light for 30 minutes before 
each use. 
 For solid culture medium, agarose was added to Z8 medium to a concentration of 1,2%. 
The mixture was spread on sterile polystyrene Petri dishes and after solidification, the 
Petri dishes were stored aseptically for further use. 
The solid Z8 medium was the primary method used to isolate cyanobacteria from the 
environmental samples. All the media for the raw environmental samples were prepared 
with cycloheximide, at a concentration of 0.025%, to prevent the growth of eukaryotic 
microorganisms. 
 
 
3.3. Identification of cyanobacteria strains 
 
3.3.1. Morphological characterization 
 
To morphologically characterize the isolates, strains were observed, annotated 
and photographed using an optical microscope (Leica DMLB) coupled to a camera (Leica 
ICC50 HD) with the Leica Qwin Color computer program (Leitz, Germany) at a 
magnification of 1000X. For each isolate, morphometric measurements were also made 
and the mean dimensions (length, width) of the vegetative cells of filaments recorded. 
Length and width were measured in 20 cells, being the cells from different individuals of 
each strain. 
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3.3.2. Molecular characterization – DNA extraction and PCR 
conditions 
 
3.3.2.1. DNA extraction 
 
To extract the gDNA from the isolated strains, a small amount of biomass was collected 
in 1.5 mL Eppendorf tubes, in the flow chamber. Tubes were centrifuged at 10000 X g 
for 1 minute to concentrate the biomass and remove the liquid in excess. The biomass 
was then stored at -20 °C for posterior extraction of DNA. 
Extraction of gDNA was performed using the Genetic DNA Mini-Kit Purelink (Invitrogen, 
USA), using the protocol for extracting DNA from gram-negative bacterial cells, 
according to the manufacturer’s instructions. Isolated DNA was stored in 1.5 mL 
Eppendorf tubes at a temperature of -20 ° C. 
To confirm that the DNA was successfully extracted an electrophoresis in Agarose gel 
(UltrapureTM Agarose, Invitrogen, USA) at 1% concentration in Tris-Acetate EDTA buffer 
solution (TAE Ultrapuretm, Invitrogen, USA) at 40mM Tris-acetate and 1mM EDTA, was 
performed. Gel was stained with 3µL of SYBRsafe (Invitrogen, USA). 
Briefly, 3 μl of extracted DNA mixed with 0.5 μl of loading buffer were loaded onto the 
gel, 1 μl molecular marker (1Kb Plus DNA Ladder-Invitrogen) was loaded. The gel was 
run at 85V for 20 minutes and visualized and photographed on the GEL DOCTM 
Molecular Imager® transilluminator with Image Lab ™ software (USA). 
 
 
3.3.2.2.  PCR amplification and analysis of products  
 
The molecular identification of isolates was based on the 16S rRNA gene. Information 
on primers is described in Table 4. 
 
Table 4 - Primer pairs used for amplification of the 16S rRNA gene 
Target 
gene Primer Primer sequence (5’_3’) Target Group 
size 
(bp) 
Referenc
e 
 
16S 
rRNA 
27F AGAGTTTGATCCTGGCTCAG 
Cyanobacteria 
754bp 
[57] 
781R GACTACWGGGGTATCTAATCCCWTT [58] 
1494R  TACGGCTACCTTGTTACGAC 1135bp [58] 
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359F GGGGAATYTTCCGCAATGGG [57]  
 
PCR reactions consisted in 1x GoTaq buffer, 2.5 mM for MgCl2, 1 µM for each primer, 
0.5 mM for the dNTP mix, 0.5 U for GoTaqR Flexi DNA polymerase. The final volume 
of each reaction was 20 µL with 1 µL of DNA template (Table 5). 
 
 
 
Table 5 - Mastermix components of the PCR reaction 
Components Volume per reaction (1x) 
Molecular biology water 7.9 µL 
5x Buffer 4 µL 
MgCl2 2 µL 
Forward primer 2 µL 
Reverse primer 2 µL 
Deoxynucleotides (dNTP’s) 2 µL 
Taq Polymerase 0.1 µL 
DNA template 1 µL 
Total: 20 µL 
 
 
The PCR reactions were performed in a Biometra T-Professional Standard Gradient 
Thermocycler (Germany) as described in table 6. 
 
Table 6 - PCR conditions used for the primer pair used to amplify the 16S rRNA gene 
Target 
gene 
 
Primer Pair 
PCR reaction References  
Initial 
Denaturation PCR cycles 
Final 
extension 
[59] RNA 
16S 
27F/359F  
95ºC 
2 mn 
 
35 Cycles 
 
 
72 ºC 
5 mn 
 
95ºC 
2 mn 
 
55ºC 
45 s 
 
72ºC 
1 mn 781R/1494R 
 
 
After amplification, all PCR products were analyzed and visualized via electrophoresis in 
an agarose gel ((Ultrapuretm Agarose, Invitrogen, USA) at a concentration of 1.5% which 
was stained with 3µL of SYBRsafe (Invitrogen, USA). The selected voltage and running 
time were 85 V and 20 minutes. The agarose gel was visualized and photographed in 
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the transilluminator Molecular Imager® GEL DOCTM with the software Image 
LabTM(USA). 
 
3.3.2.3.  Sequencing, sequence alignment and phylogenetic 
analysis 
 
All the samples that exhibited positive PCR results (i.e presence of the gene) were 
selected for sequencing. The 16S rRNA gene was firstly amplified and sequenced for all 
the isolates obtained, in order to identify the cyanobacteria and thus assess the diversity 
of the samples. For sequencing purposes, the PCR preparation involved duplicating the 
number of reactions for each isolated sample, in order to have enough amplified product 
to enable sequencing. So, the final volume of PCR product per sample loaded into the 
1.5% agarose gel was 40 µL. The electrophoresis was runed at 90 V for 60 minutes, 
then the amplified fragments was observed in the CSMICRODOC system (Cleaver 
scientific, UK) transilluminator coupled with a Canon PowerShot G9 camera. The bands 
with the expected size were excised from the gel and collected to be purified using the 
Nztech – genes & enzymes (NZYGelpure, Portugal) purification kit, following the 
manufacturer’s instructions. To check the efficacy of the DNA purification, an 
electrophoresis (100V; 20 minutes) was run in a 1% agarose gel, and 2 µL of the purified 
DNA was mixed with 1 µL of loading buffer. All the purified PCR products and the 
respective pair of primers was sent to GATC Biotech (Germany) to be sequenced. 
The forward and reverse sequences (i.e. 5’ and 3’) obtained from the same PCR product 
were examined in the bioinformatic software Geneious (v.8) and assembled together (de 
novo assembly), their chromatograms were analyzed to check the quality of the 
sequences and to determine if further sequences were needed to form a consensus 
sequence (i.g. if the quality was bad on either one of the forward or reverse sequences). 
The sequences usually be trimmed at the extremities due to bad quality. Then, the 
consensus sequences of each strain isolate were compared with the sequences in the 
GenBank® database using the BLAST®n (Basic Local Alignment Search Tool for 
nucleotides) tool available in the NCBI (National Center for Biotechnology Information) 
and compared with other cyanobacterial sequences in the GenBank® database to check 
for similarities and to help in their identification. To settle the phylogenetic relation of the 
isolated strains to other reference strains, the sequences were aligned by ClustalW, and 
the GTR+G+I evolutionary model was selected by MEGA 7.0. The robustness of 
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Maximum Likelihood (ML) trees was estimated by bootstrap percentages, using 1000 
replications in MEGA 7.0. 
 
3.4. Cyanobacteria culture and extraction 
 
For stock and culture, the cyanobacteria strains were inoculated in 500 mL and 4 liters 
of Z8 medium (with 25g/L NaCl) respectively. Cultures in 4L medium were maintained 
under an aeration system. All the procedures were performed in controlled temperature 
conditions (25 °C) and luminance (light cycles / dark 14h / 10h). When cultures reached 
the exponential growth stage, after approximately 30 days of the inoculation, visually 
recognized by the high concentration of biomass (Figure 2), the cultures were harvested 
by filtration. 
 
 
 
                           Figure 3 - Cyanobacteria cultures after 25 days growth. 
 
 
Before lyophilization, the concentrated biomass was stored at – 80ºC. The frozen 
biomass was lyophilized for 7 days at -48ºC (Telstar LyoQuest) under reduced pressure 
(0.1 mbar with condenser at -47 ºC) and stored at -20ºC until further use.  
A smaller stock culture of all cyanobacteria strains was maintained during this work in 
order to provide biomass to inoculate in the 500 mL medium. This stock culture was 
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performed by removing a small amount of biomass of the culture and placing it in flasks 
with 100 ml of Z8 medium (25g/L NaCl). 
 
 
The cyanobacterial extracts were performed with lyophilized material. The extraction was 
started by breaking the lyophilized biomass using a mortar and porcelain pestle, in small 
portions at a time, transferring the grounded biomass to an Erlenmeyer flask. After, 50 
ml of methanol were added, and the flask placed in the ultrasonic bath for 5 minutes 
(taking care not to heat above 30 ºC). The flask was rested for a few minutes, letting the 
particulate matter settle to the bottom. The supernatant was filtered using a vacuum 
filtering system as describe in the Fig. 4. This procedure was repeated twice using 25 
mL of methanol. The final extract was concentrated in a round flask on a rotary 
evaporator at 30 ºC, under a control pressure. The concentrated extract was transferred 
to a pre-weighed 20 mL vial, by filtering it through a Pasteur pipette with a cotton filter 
(to capture any non-soluble material). Finally, the solvent was evaporated in a rotary 
evaporator and the flask was left in high vacuum to thoroughly dry. The glass vial was 
weighted again, and the total mass of the crude extract calculated. The dry extract was 
dissolved at the concentration of 10 mg/mL using DMSO and stored at -20 ºC. 
 
 
 
Figure 4 - Extraction system from lyophilized cyanobacterial material (according to the MeOH 
extraction SOP V12.2019 protocol from BBE.CIIMAR). 
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3.5. Cytotoxicity analysis 
 
3.5.1 Cell culture 
 
The bioactivity of the extracts was assessed using normal and cancer cell lines (Table 
7). 
 
Table 7 - Cell lines included in the study 
Cell Cell line Origin 
Hepatic carcinoma cells HEPG2 American Type Culture Collection (ATCC) 
Colon carcinoma cells RKO American Type Culture Collection (ATCC) 
Breast adenocarcinoma 
cells T47D Sigma-Aldrich  
Keratinocytes  HaCaT American Type Culture Collection (ATCC) 
Endothelial cells  hCMEC/D3 Donated by Dr. PO Couraud (INSERM, France) 
 
Cells were cultured in DMEM Glutamax medium (Dulbecco’s Modified Eagle Medium 
DMEM GlutaMAXTM – Merck, Germany), supplemented with 10% (v/v) fetal bovine 
serum (Gibco, USA), 0,1% Amphotericin B (Gibco, Germany) and 1% of penicillin-
streptomycin (Pen-Strep 100 IU/ml and 10 mg/ml, respectively) (Gibco, Germany) in a 
humidified atmosphere containing 5% CO2 and at 37ºC. Culture medium was renewed 
every two days. At 80-90% cell confluence, adherent cells were washed with phosphate-
buffered saline (PBS) (Gibco, Germany) and enzymatically released with TrypLE 
express enzyme (1x) (Gibco, Denmark).  
 
3.5.2 Cytotoxicity assay – MTT assay 
 
The viability of cells exposed to the cyanobacteria extracts was evaluated by using the 
3- (4,5 dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The MTT is 
FCUP 
Cyanobacteria from Cape Verde Islands: a contribution to the diversity and biotechnological 
potential 
 
 
 
20 
a yellow tretazole soluble in water that is reduced by mitochondrial enzymes to purple 
formazan crystals that are insoluble in water. The reduction of MTT to formazan is directly 
proportional to the mitochondrial activity and consequently cell viability ( [61]. 
 
For the cytotoxic assays cells were seeded in 96-well culture plates at a density of 2,5 x 
104 cells mL-1 for keratinocytes, 1 x 105 cells mL-1 for endothelial cells and 3.3 x 104 cells 
mL-1 for T47D, RKO and HepG2 cells. After 24 hours of adhesion, cells were exposed to 
100 μL fresh medium supplemented with the extracts to a final concentration of 100, 75, 
50, 25, 12,5 and 6,25 µg mL-1 for a period of 24 and 48 hours. After each incubation time, 
an aliquot of 20 μL MTT solution (1 mg mL-1) was added to each well in medium and 
incubated at 37 ºC for 3h.  After the incubation time, the medium was carefully aspirated, 
and the purple colored formazan salts dissolved in 100 μL DMSO.  Absorbance was read 
at 550 nm in using a Synergy HT Multi-detection microplate reader (Biotek, Bad 
Friedrichshall, Germany) operating by GEN5TM software.  
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4. Results and Discussion 
 
4.1. Isolated strains and identification 
The isolation procedure, as well as time consuming, does not isolate all the diversity in 
a sample collected at a given location. A total of twenty isolates were obtained (Table 8 
and Figure 5). All the isolated were obtained by petri dish spreading. From the total, 
nineteen strains were isolated from São Vicente island and one strain was isolated from 
Santo Antão. Due to time constraints deadlines only Z8 medium was used. Although Z8 
medium is a nutrient rich medium and widely used in the isolation of cyanobacteria, it 
may not have facilitated the isolation of some groups, namely coccoid forms and 
heterocystous forms. In this sense other media may be used in the continuation of the 
work, such as culture medium BG110.  
For the identification of the isolates, a polyphasic approach was followed. These included 
morphological characteristics such as the presence of specialized cells and cell size, and 
molecular tools such as the amplification and sequencing of the 16S rRNA gene [62].  
As we can see in the Table 8 the morphological diversity of cyanobacteria is quite 
variable, however, it is verified that the isolates obtained from different places of the 
Islands have some peculiar and distinct characteristics. All the isolates are filamentous 
and no specialized cells such as heterocysts are present. This might be due to the faster 
growth occurring in Z8 medium, which seemed to favor the growth of non-heterocystous 
strains.  
There are isolates that have filaments with rounded end cells, others that have slightly 
arched filaments at the ends and other cellular constrictions at wall level. Still others have 
thin filaments that coil, some in the shape of a ball. The isolates color ranged from green, 
dark green, brownish to reddish. By the color it was possible to conclude that the strains 
JM1C, VV2, VV3 and VV5 are rich in phycoerythrin responsible for the reddish color 
(Figure 5). These may be interesting to produce the red pigment that can potential be 
use as a natural colorant for the food and cosmetic industry.   
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                                Table 8 - Isolated strains, morphological characteristics. 
Sampling site Original Label 
Isolate 
code 
Color in 
culture Morphological characteristics 
Cell size (Width x Length ) 
µm 
São Vicente 
Baía das Gatas JM1 
JM1B Cyano Filaments with sheath 1,2±0,1x1,3±0,3 
JMIC Reddish Filaments with trichomes constricted at cross walls 1,6±0,2 x 1,6±0,3 
B. das Gatas PL1 PL1 Cyano Filaments with sheath and terminal cells rounded 2,4±0,5 x 2,7±0,8 
B. das Gatas PL2 PL2 Cyano Filaments with sheath 2,3±0,5 x 4,7±1,4 
B. das Gatas PL3 PL3 Cyano Filaments with sheath 2,3±0,2 X 3,0±1,0 
B. das Gatas VV1 VV1 Cyano Filaments with sheath 1,4±0,2 x 1,4±0,2 
Calhau VV9 VV9 Dark brown Filaments with some helical filaments, forming tuft like aggregates 1,8±0,2 x 1,5±0,3 
Calhau VV10 VV10 Cyano Thin, coiled filaments wrapped in mucilage 1,1±0,2 x 1,4 ±0,4 
Cova da Inglesa VV5 VV5 Brownish Filaments growing homogeneously, but also forming aggregates 1,5±0,3 x 1,5±0,3 
C. da Inglesa JM5 JM5A Cyano Filaments with sheath 1,2±0,3 X 1,1±0,2 
Praia da Laginha VV2 VV2 Reddish Trichomes slightly constricted at cross walls 1,8±0,3 X 1,4±0,3 
P. da Laginha VV3 
VV3 Reddish Thin, coiled filaments wrapped in mucilage 1,2±0,3 x 1,2±0,3 
VV3A Green olive Filaments growing homogeneously, but also forming aggregates 1,4±0,2 x 1,4±0,2 
VV3B Dark green Filaments growing homogeneously, but also forming aggregates 1,1±0,18 x 1,2±0,3 
P. da Laginha  VV4 VV4 Reddish  Trichomes slightly constricted at cross walls  1,7± 0,3 X 1,6±0,2  
Salamansa VR5 VR5 Cyano Filaments forming a smooth biofilm 1,1± 0,2 x 1,2±0,2 
Salamansa VV6 VV6 Cyano Filaments growing homogeneously, but also forming aggregates 1,2±0,1 x 1,4±0,3 
Salamansa VR7 
VR7A Cyano Filaments growing homogeneously also forming aggregates 1,6±0,3 x 1,6±0,4 
VR7B Dark green Thin, coiled filaments wrapped in mucilage 1,3±0,3 x 2,2±1,0 
Santo Antão 
Ponta do Sol VV13 VV13 Reddish Brawn Filaments with sheath and rounded cells rounded 1,9±0,4 x 1,7±0,5 
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Figure 5 - Photomicrographs of the cyanobacteria isolates. 
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4.2. Phylogenetic analysis 
 
The identification of the cyanobacteria isolates by a molecular approach was based in 
the 16S rRNA gene sequences. In Table 9 it is presented the best BLAST results 
obtained from Genbank for the consensus sequence of sixteen of the isolates. The 
sequences of the BLAST results from the isolates of this study and a subset of 56 
sequences representing cyanobacterial diversity (obtained from the online database 
Cyanotype) were integrated into the phylogenetic tree shown in Figure 6. 
 
 
Table 9 - Best Blast results obtained for each isolate based on the molecular marker 16S 
rRNA 
 
 
 
 
 
 
 
Isolate 
Code Molecular Identification (ID) (top cyano hit) % ID 
Sequence 
Length 
bp 
JM1B Filamentous cyanobacterium ESFC-1 clone 4_5A 16S ribosomal RNA gene 96.45% 733 
JM1C Leptolyngbya sp. RS02 16S ribosomal RNA gene 99.8% 1363 
PL1 Oscillatoria sp. S8 16S ribosomal RNA gene 99.72% 1053 
VV1 Nodosilinea sp. LEGE 11468 16S ribosomal RNA gene 99.62% 1330 
PL2 Geitlerinema sp. PCC 7105 small subunit ribosomal RNA gene, partial sequence 99.49% 1369 
VV9 Leptolyngbya sp. PCC 7376, complete genome 99.26% 1355 
VV10 Filamentous cyanobacterium 73-2 16S ribosomal RNA gene 97.69% 1382 
JM5A Nodosilinea sp. LEGE 11468 16S ribosomal RNA gene 99.26% 1079 
VV2 Leptolyngbya sp. RS02 16S ribosomal RNA gene, partial sequence 99.22% 1279 
VV3 Phormidium angustissimum SABC020801 16S ribosomal RNA gene 96.71% 1370 
VV3A Filamentous cyanobacterium 73-2 16S ribosomal RNA gene 99.98% 1372 
VV3B Filamentous cyanobacterium 73-2 16S ribosomal RNA gene 99.13% 1375 
VV6 Filamentous cyanobacterium 73-2 16S ribosomal RNA gene 99.13% 1380 
VR7A Filamentous cyanobacterium 73-2 16S ribosomal RNA gene 99.12% 1366 
VR7B Nodosilinea sp. LEGE 11468 16S ribosomal RNA gene, partial sequence 99.62% 1042 
VV13 Leptolyngbya ectocarpi LEGE 11474 16S ribosomal RNA gene 97.73% 1189 
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In the total of 20 isolated strains, 16 could be analyzed through molecular tools while 
for VV5, VR5, PL3 and VV4 only morphological characteristics were able to be 
determined.  
The ML tree shows the sequences from the isolates and reference strains of 
cyanobacteria, in order to verify the diversity of the obtained isolates.  
The phylogenetic tree consisted of 25 clusters (Figure 6), which were defined by 
being monophyletic groups with a bootstrap value of 70% or higher and had to 
include at least 1 isolate strain or 1 reference strain. An exception was made to the 
Cluster Y and X which had a bootstrap value lower than 50% but was defined as a 
cluster because it is a monophyletic group that includes the isolate strain. Clade N 
(Figure 6) includes  PL1 and PL2, being supported by a high bootstrap value (100%) 
and is close related (boostrap 94%) to Lyngbya cf. confervoides AY599507, which 
cannot be assigned as a reference strain for Lyngbya. Because of that, this clade is 
worthy to be described as a new cyanobacterial genus in further studies. 
Clade S (Figure 6) also does not include a reference strain and is phylogenetically 
strongly supported (bootstrap 100%). It includes the isolated strain VV9 identified, 
which is phylogenetically close related to Leptolyngbya PCC7376 and the respective 
best hit that is an unidentified 4Oscillatoria_rosea_IAM. This clade is also worthy to 
be described as a new cyanobacterial genus in further studies.  
The clade T is identified as Jaaginema, and includes the isolate obtained in this study 
JM1B the best hit strain to Jaaginema strain JaaginemaspPsrJGgm 14 and 
JaaginemaspIkpSMP32 which are non-heterocyst filamentous, usually of very simple 
and thin morphology and without large distinctive characters [13] and one 
JQ013010_Filamentouscyanobacte. 
The Clade X was subdivided into 2 subclades (Figure 6) subclade X1 included  
comprises 5 isolated strains (VV10,VV6,VV3A,VV3B,VR7A, VV3) all identified as 
belonging to not already described genera. The subclade X2 (figure 6) was integrated 
by 3 isolates strains VV13, JM1C and VV2 identified as a Leptothoe_TAU_MAC_161 
and Leptolyngbya_sp_HBC2,it is important to refer that the VV13,JM1C and VV2 
beside they are phylogenetically positioned in the same clade, their morphological 
characteristics  are very similar even to they were collected from different places. 
Clade Y (figure 6) comprised of 3 isolate strains VR7B,JM5A the Best hit strains 
Nodosilinea and Leptolyngbya_sp_LEGE_0 and VV1 the Best hit strains 
Leptolyngbya_sp_CENA15 and Haloleptolyngbyaalcali with a low bootstrap value 
(<50 %) this clade was only defined to illustrate the close proximity of the isolates. 
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In a general analysis we verified the presence of genera of common cyanobacteria 
in marine benthonic environments such as the genus Leptolyngbya. The most 
striking result was the possibility that most strains belong to new filamentous genera. 
In order support the 16S rRNA-based classification of cyanobacteria other molecular 
tools may be suggested such as the DNA-dependent RNA polymerase gamma 
subunit (rpoC1), and and  an in-depth morphological evaluation using electron 
microscopy. Being new genera, this work allows to contribute to the knowledge of 
cyanobacteria  by revealing unreported cyanobacterial diversity.  
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Figure 6 - Phylogenetic distribution based on the 16S rRNA of isolates (red) with the respective Best Hits. 
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4.3. Bioactivity 
 
The potential bioactivity of the extracts was assayed against cancer and normal cell lines. 
For the evaluation of the anticancer potential, three cancer cell lines representative of 
major cancers affecting humans were selected, hepatic carcinoma cells HepG2, colon 
carcinoma cells RKO and breast adenocarcinoma cells T47D. Since the potential utility 
of the cyanobacteria extracts as anticancer drugs depends on the degree of selective 
toxicity on tumor cells, sparing normal cells, two normal cells were selected, the 
keratinocytes cell line HaCat and the endothelial cell line hCMEC/D3. The selection of 
these two normal cell lines was also based in the potential for skin care application that 
the cyanobacteria strains might revealed since keratinocytes are the major epidermis 
cells and endothelial cells are major blood vessels cells. The cytotoxicity of the 
cyanobacteria extracts was assayed by the MTT assay. The MTT assay is a widely used 
cytotoxic assay that measures cellular viability and thus, indirectly, cell proliferation. The 
assay was performed with the extract of the isolated strains at concentrations of 100μg 
mL-1; 75μg mL-1; 50μg / mL-1; 25μg mL-1; 12.5μg mL-1 and 6μg mL -1 and exposure times 
of 24 and 48 hours. In all the assays the solvent control consisted in 1% DMSO in cell 
culture medium. Values are expressed as mean ± SD, n=3. Results obtained are presented 
in Figures 6-18 and a summary is presented in Table 10. 
 
 
Figure 7 - Cellular viability of cells exposed to the extract of strain JM1C. 
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Figure 8 - Cellular viability of cells exposed to the extract of the strain JM1B. 
 
 
Figure 9 - Cellular viability of cells exposed to the extract of the strain PL1 
 
 
 
Figure 10 - Cellular viability of the cells exposed to the extract of the strain PL2 
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Figure 11 - Cellular viability of the cells exposed to the extract of the strain VV9 
 
 
 
Figure 12 - Cellular viability of the cells exposed to the extract of the strain VV5 
 
 
 
Figure 13 - Cellular viability of the cells exposed to the extract of the strain JM5A 
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Figure 14 - Cellular viability of the cells exposed to the extract of the strain VV3 
 
 
Figure 15 - Cellular viability of the cells exposed to the extract of the strain VV3B 
 
 
 
Figure 16 - Celular viability of the cells exposed to the extract of the strain VR7A 
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Figure 17 – Cellular viability of the cells exposed to the extract of the strain VR7B 
 
 
Figure 18 - Cellular viability of the cells exposed to the extract of the strain VV13 
 
By analyzing the results, we can see that the results showed both a reduction and 
increase in cells viability. The strain JM1C was the most toxic one inducing a decrease 
in cell viability in all tested cell lines, especially after 48 hours incubation (Figure 7). This 
reduction was particularly evident in the endothelial cells and in the keratinocytes cell 
line. Although no selectivity between the different cell lines is evident, the cytotoxicity 
registered reflects the presence of bioactive compounds with potential anticancer effect. 
Since only one crude extract has been tested and it represents a mixture of compounds, 
this strain is interesting for the isolation of compounds which, once isolated, may exhibit 
differential bioactivity in different cell lines (      colour in Table 10). 
The strain JM1B is particularly interesting since different responses were obtained with 
the three different cancer cell lines. The extract of this strain induced a higher reduction 
of the cellular viability of the breast adenocarcinoma cell line T47D, especially after 48 
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hours incubation, with a reduction of nearly 70% in cell viability at all extract 
concentration (Figure 8). Although a reduction in cell viability of the normal endothelial 
cells hCMEC/D3 was also registered, this was between 30% and 40% for the 100 μg mL-
1,50 μg mL-1,25 μg mL-1 and only 20% and 12% for the 12,5 μg mL-1,and 6,25 μg mL-1 
concentrations respectively. The higher cytotoxicity of the extract to the T47D cell line in 
all concentrations compared to the slight cytotoxicity of the extract to the hCMEC/D3 cell 
line at the two lower concentrations tested, indicate the selectivity of the extract 
concerning the cancer cell line and the normal cell line. Also, the lower cytotoxicity 
registered for the hepatic carcinoma cell line HepG2 and the colon adenocarcinoma cell 
line RKO, indicates selectivity among cancer cell lines. This cyanobacteria strain is, in 
this study, one of the strains that further extract fractionation should be performed in 
order to isolate bioactive compounds with potential anticancer interest (      colour in 
Table 10)..  
The extract of the strain PL1 revealed no cytotoxicity for the cancer cell lines HepG2 and 
RKO and the normal cell line hCMEC/D3, however, a reduction between 50% and 40% 
was obtained with the keratinocytes cell line after 48 hours incubation (Figure 9). The 
same pattern was registered with the extract of the strain PL2 where only a slight 
decrease in cell viability at the concentrations higher than 25 μg mL-1 was registered in 
the cancer cell lines and a reduction of cell viability between 40-50% was obtained with 
the keratinocytes cell line (Figure 10). Although to a lesser extent, the results of 
cytotoxicity with the strain VV9 are similar with the two previous strains. This strain 
induced no toxicity or a slight toxicity against the cancer cell lines and the endothelial 
cells and a slightly higher cytotoxicity against the keratinocytes (Figure 11). 
With the strain VV5, a reduction in cell viability, that reached 70%, was registered 
particularly after 48 hours incubation and especially for cells RKO and T47D (Figure 12). 
On the oposite, an increase in cell viability was registered for the keratinocytes HaCat. 
The same pattern was obtained with strains VV3 (Figure 14), VV3B (Figure 15) and VV13 
(Figure 18). In addition to JM1C and JM1B these are also interesting strains to continuing 
for the isolation of bioactive compounds, in this case with anticancer potential and 
potential for the use on skin care products (   Colour in Table 10). Concerning 
keratinocytes these are the major constituents of the epidermis which is the superficial 
layer of the skin and the primary defense against exogeneous factors such as UV 
radiation, pollution and cold [63]. In order to protect against these exogenous factors, 
skin regenerative actions occur, such as the proliferation of keratinocytes. The 
cyanobacteria strains that induced keratinocytes proliferation are thus interesting for the 
isolation of compounds with this potential. With these four cyanobacteria strains the 
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increase in keratinocytes viability was in fact evident. With the VV3 strain a percentage 
of cell viability up to 140% in the concentration of 100 μg mL-1 ,120% at the concentration 
of 50 μg mL-1,12,5 μg mL-1,6,25μg mL-1 and up to 80% in the concentration of 75 μg mL-
1 for 24 hours after the exposure and for 48 the cell viability was up 160% for all 
concentrations was obtained (Figure 13). An increase of viability was also observed for 
a VV3B strain in the keratinocytes which obtained a percentage of cell viability up 100% 
in the concentration of 100 μg mL-1,120% of 75 μg mL-1 and then up to 140% the 
concentration of  50 μg mL-1,25 μg mL-1,12,5 μg mL-1,and 6,25 μg mL-1 for 24 hours and 
which obtained a percentage of cell viability up to 80% at the concentration of 100 μg 
mL-1,50 μg mL-1,25 μg mL-1 ,100% at the concentration of 75 μg mL-1 and then 120% at 
the concentration of 12,5 μg mL-1,6,25 μg mL-1(Figure 14) for 48 hours. For the VV5 
strain as well in keratinocytes an increase of viability was obtained which at the 
concentration of 100 μg mL-1and 50 μg mL-1  a  percentage up to 100% was obtained and 
120% at the concentration of 75 μg mL-1,25 μg mL-1,12,5 μg mL-1,6,25 μg mL-1 for 24 
hours and up to 140%  for all the extract concentration after 48 hours(Figure 11) Even 
as VV3 strain we can see an increase of the viability of the cell after 48 hours of the 
exposure. For a VV13 strain also we can see that the highest the cell viability was 
observed in the keratinocytes which displayed a percentage of cell viability up to  100% 
at the concentration of  100 μg mL-1, 120% at the concentration of  75 μg mL-1,50 μg mL-
1,160% at the concentration of 25 μg mL-1,12,5 μg mL-1,6,25 μg mL- for 24 hours and for 
48 a percentage of cell viability up to 80% for the concentration 100 μg mL-1,up to 100% 
for the concentration of 75 μg mL-1,50 μg mL-1 and up 25 μg mL-1,12,5 μg mL-1,6,25 μg 
mL-1(Figure 17). 
The cytotoxicity results obtained with the strains JM5A and VR7A were similar since the 
extracts affected more the T47D cells following the HepG2 cells and with no cytotoxicity 
against the RKO cells. As for strain JM1B, these results point to a selective toxicity of 
the extracts towards different cancer cell lines being thus also interesting for the isolation 
of potential anticancer compounds (      . colour in Table 10). 
Considering the endothelial cells hCMEC/D3, strains PL1, PL2 and VV9 induced cell 
proliferation (Figures 9, 10 and 11). This result is also interesting concerning skin care, 
since skin is a higly irrigated organ being irrigation closely linked to skin  regeneration 
[64].  
In general, there was some selectivity of the extracts, both in the whole of the cancerous 
lines and normal lines and between the normal lines and the cancerous lines. These 
results support the presence of compounds with bioactive activity that will be interesting 
to explore.  
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Table 10 - Summary of the cell viability results obtained with the MTT assay for each of the cyanobacteria strains and cell 
lines. +++ cell viability higher than 100%; ++ cell viability 100%-80%, + cell viability 80-70% and - cell viability lower than 
70%. 
Isolates 100 µg mL
-1 75 µg mL-1 50 µg mL-1 25 µg mL-1 12.5 µg mL-1 6.25 µg mL-1 
24h 48h 24h 48h 24h 48h 24h 48h 24h 48h 24h 48h 
RKO 
JM1C - - - - - - - - - - - - 
JM1B +++ +++ +++ ++ +++ ++ +++ ++ +++ ++ +++ ++ 
PL1 +++ ++ +++ ++ +++ ++ +++ +++ +++ +++ +++ ++ 
PL2 +++ - +++ - +++ ++ +++ +++ +++ ++ ++ ++ 
VV9 +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ ++ - 
VV5 +++ - ++ - ++ - ++ - ++ - ++ - 
JM5A ++ ++ ++ ++ +++ +++ +++ +++ +++ +++ +++ +++ 
VV3 ++ - ++ - ++ - ++ - ++ - ++ - 
VV3B + - + - ++ - ++ - ++ - ++ - 
VR7A +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
VR7B +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ ++ +++ 
VV13 ++ - ++ - ++ - ++ - ++ - ++ - 
HepG2 
JM1C - - - - - - - - - - + - 
JM1B ++ + + ++ ++ ++ ++ ++ ++ + ++ + 
PL1 +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
PL2 +++ + +++ ++ +++ ++ +++ +++ +++ +++ +++ ++ 
VV9 +++ ++ +++ ++ +++ ++ +++ ++ +++ +++ +++ +++ 
VV5 ++ ++ +++ ++ ++ ++ ++ + ++ + ++ + 
JM5A - ++ - +++ - +++ + +++ + +++ ++ +++ 
VV3 +++ + ++ + ++ + +++ ++ ++ + ++ ++ 
VV3B ++ + ++ + ++ + +++ ++ +++ ++ +++ +++ 
VR7A - +++ - +++ - +++ - +++ + +++ + +++ 
VR7B +++ ++ +++ ++ +++ ++ +++ ++ - +++ - +++ 
VV13 ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ + 
T47D 
JM1B + - - - + - + - + - + - 
VV3 + - + - + - ++ - ++ - ++ - 
VV3B ++ - ++ - ++ - ++ - +++ - +++ - 
VV5 + - + - ++ - ++ - ++ - ++ - 
JM5A - - + - ++ - +++ - +++ - +++ - 
VR7A + - + - ++ - ++ - +++ - +++ - 
hCMEC/D3 
JM1C - - - - - - - - ++ - ++ - 
JM1B - - - + - - - + + + ++ ++ 
PL1 ++ ++ +++ ++ +++ +++ +++ +++ +++ +++ +++ +++ 
PL2 +++ ++ +++ ++ +++ ++ +++ +++ +++ +++ +++ +++ 
VV9 +++ ++ +++ ++ ++ ++ +++ +++ +++ ++ +++ ++ 
VV5 - - + - - - + - - - - - 
JM5A - - - + - + + ++ ++ ++ ++ +++ 
VV3 - - - - - - ++ - ++ - ++ - 
VV3B - - - - - - + - + + ++ + 
VR7B ++ ++ ++ ++ ++ ++ +++ +++ +++ +++ +++ +++ 
VV13 - - - - - - - - - - - - 
HaCat 
JM1C - - - - - - - - - - - - 
PL1 - - + - ++ - ++ - ++ - ++ - 
PL2 - - - - ++ - ++ - ++ - - - 
VV9 + - ++ ++ + +++ ++ +++ + ++ ++ ++ 
VV5 +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
VV3 +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
VV3B +++ ++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
VR7B ++ ++ ++ + ++ ++ ++ ++ ++ +++ ++ ++ 
VV13 +++ ++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
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5. Conclusions 
The present work constituted a preliminary contribution for the study of the biodiversity 
and bioactive potential of cyanobacteria from Cape Verde Islands. From the collected 
samples 20 filamentous cyanobacteria strains were isolated. Since the cyanobacteria 
isolation process is very time consuming, it was not possible to isolate more strains within 
the time of this thesis. This isolation process is however being continued. The 
phylogenetic analysis reveals the possibility that strains belong to new genera, which 
contributes to enrich the diversity that occurs within this group of organisms. 
Considering the bioactive assays performed using human cell lines it was possible to 
infer about the potential of some of the strains namely by the observed selective toxicity 
towards cancer cells and the induced proliferation of keratinocytes and endothelial cells. 
Although only a crude methanolic extract was tested, the bioactivity results are promising 
for the isolation of compounds with potential anticancer activity. Since  only a crude 
extract, and therefore a cocktail of compounds was tested, fractionation becomes 
important. In this sense, the results obtained allowed a selection of strains which crude 
extract will be further fractionated in order to isolate the bioactive compounds. 
Far from being completed this study represents the first approach to the study of the 
biodiversity and biotechnological potential of cyanobacteria from Cape Verde. 
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